准元可塑性机制,以促进持续的抗抑郁作用
Kyle A Brown1, Todd D Gould2,3,4,5
1Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, 21201, USA.
Molecular psychiatry
|January 4, 2024
概括
快速起作用的抗抑郁药物,如胺 (ketamine) 和胺 (esketamine),为治疗耐药抑郁症提供了新的希望. 这些药物利用元可塑性,一种大脑机制,以增强突触可塑性,并提供持续的抗抑郁药物效应,剂量较少.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 精神病学是一个精神病学.
背景情况:
- 低麻醉剂量的胺和胺快速诱导治疗耐药抑郁症的抗抑郁作用.
- 这改变了抑郁症治疗的概念,促使研究下一代抗抑郁药.
- 受损的激发性谷氨基质突触与抑郁症病理生理学有关.
研究的目的:
- 审查快速起作用抗抑郁药的下游分子机制的证据.
- 探索超塑性在中介持续抗抑郁药效应中的作用.
- 确定超塑性作为未来抑郁症治疗的可用药物标.
主要方法:
- 审查关于胺,胺和其他快速起作用的抗抑郁药物的现有科学文献.
- 对各种抗抑郁药启动机制下游的分子媒介的分析.
- 检查突触可塑性和超可塑性在抗抑郁药作用中的作用.
主要成果:
- 不同的快速作用抗抑郁药汇聚在常见的下游分子媒介上.
- 这些介质促进了突触强度的增加和持久的抗抑郁药物效应.
- 代塑效应对于这些药物的持续治疗作用至关重要.
结论:
- 转塑性代表了下一代抗抑郁药的可药性机制.
- 向超塑性提供了诸如降低剂量频率和减少不良影响等优势.
- 利用超塑性可以通过增强激发性神经传递来逆转抑郁病理生理学.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
239
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
239
Long-term Depression
2.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.5K
Long-term Potentiation
2.8K
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Hebbian LTP
LTP can occur when...
Hebbian LTP
LTP can occur when...
2.8K
Antidepressant Drugs: Overview
503
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
503
Desensitization and Tachyphylaxis
1.7K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.7K
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
398
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
398


